Surrogate Endpoint
Clinical Trials
A surrogate endpoint is a measurable marker (such as tumor shrinkage or a lab value) used as a stand-in for a direct clinical outcome like survival. Surrogates can shorten trials and underpin Accelerated Approval, but they must be reasonably likely to predict real benefit.
Related terms
Track Surrogate Endpoint across 1,000+ biotechs
BioSniper monitors FDA decisions, clinical trials, and catalysts in real time — with evidence-backed AI analysis.
Start Free